Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-13-000012)

Filing Details

Accession Number:: 0000711377-13-000012
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-29 16:14:20
Reporting Period:: 2013-04-25

Filing Date:: 2013-04-29
Accepted Time:: 2013-04-29 16:14:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1189021	Edward Bradley		Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-04-25	27,062	$6.75	148,749	No	4	M	Direct
Common Stock	Acquisiton	2013-04-25	1,049	$18.19	149,798	No	4	M	Direct
Common Stock	Disposition	2013-04-25	28,111	$50.21	121,687	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2013-04-25	27,062	$0.00	27,062	$6.75
Common Stock	Common Stock (Right to Buy)	Disposition	2013-04-25	1,049	$0.00	1,049	$18.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
123,820		2013-10-10	No	4	M	Direct
122,771		2013-08-15	No	4	M	Direct

Footnotes

Options were NQs granted on 10/10/2003, vesting over 5 years, with an expiration date of 10/10/2013
Options were NQs dated 8/15/2008, with 5 year vesting, expiring on 8/15/2013